Prognostic significance of reactivation of telomerase in breast core biopsy specimens.

Published

Journal Article

BACKGROUND: Telomerase is not expressed in most somatic tissues, but activity has been shown in breast carcinoma and up to 90% of solid tumors. We sought to determine whether activation of telomerase, as shown by immunohistochemical staining for human telomerase reverse transcriptase (hTERT), held prognostic significance in core breast biopsy specimens. METHODS: We identified women with atypical ductal hyperplasia (ADH) on core biopsy who either had underlying cancer or ADH. Immunohistochemistry with anti-hTERT antibody was performed on biopsy specimens, and staining was evaluated. RESULTS: Core biopsy specimens stained strongly with the hTERT antibody in 7 (70%) specimens with ADH on open biopsy and 6 (86%) with underlying cancer. The difference was not statistically significant (P = .43). CONCLUSIONS: Our study suggests telomerase may be activated early in the pathogenesis of breast cancer. The immunohistochemical evaluating expression of hTERT does not reliably identify those patients with ADH on core biopsy who are likely to have cancer.

Full Text

Duke Authors

Cited Authors

  • Herbert, GS; Sohn, VY; Mulcahy, MJ; Champeaux, AL; Brown, TA

Published Date

  • May 2007

Published In

Volume / Issue

  • 193 / 5

Start / End Page

  • 547 - 550

PubMed ID

  • 17434352

Pubmed Central ID

  • 17434352

Electronic International Standard Serial Number (EISSN)

  • 1879-1883

Digital Object Identifier (DOI)

  • 10.1016/j.amjsurg.2007.01.011

Language

  • eng

Conference Location

  • United States